TP53 and endometrial cancer: In the two predominant endometrial cancer histological subtypes, endometrioid and serous, TP53 and ARID1A alterations co-occurred less frequently than expected by chance in primary tumors (two-tailed Fisher’s exact test, Fig 1C).